Endpoints News 生物医药· ENDPOINTS·· 2026-10-01AI 评分19
United Therapeutics 赢得诉讼;BMS 获批 Camzyos 儿科适应症
United Therapeutics' legal victory; BMS' Camzyos approved for kids
AI 导读
United Therapeutics 在联邦法院赢得法律胜利。BMS 的 Camzyos 获批用于儿科患者。新闻还包括 Novo、Nektar 等企业动态。
正文
Plus news about Novo, Nektar, MindRank, Mabwell Bioscience, Atara Biotherapeutics, Pierre Fabre, Monte Rosa and Skopos Bio.
United Therapeutics wins court battle: A federal court …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news